Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of Ixabepilone Plus Trastuzumab vs. Docetaxel Plus Trastuzumab in Female Subjects With Her2+ Locally Advanced and/or Metastatic Breast Cancer

NCT00490646 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT00490646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00490646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of Ixabepilone Plus Trastuzumab vs. Docetaxel Plus Trastuzumab in Female Subjects With Her2+ Locally Advanced and/or Metastatic Breast Cancer
Lead sponsor
R-Pharm
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2011
Enrollment
50 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer